Filing Flows › Ducommun (DCO) › Stock forecast & fair value
Ducommun (DCO) stock forecast and fair value
Ducommun (DCO) trades at $170.76. 6 analysts' median price target is $211.00 (+24%), from $155.00 to $246.00. Across 13 valuation methods the middle fair value is $42.02 (-75%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| EV/EBITDA vs peers | $1.69 | $8.33 | $29.77 | -95% |
| EV/EBITDA vs peers, weighted | $1.41 | $7.71 | $11.81 | -95% |
| EV/Sales vs peers | $81.35 | $145.38 | $525.10 | -15% |
| EV/Sales vs peers, weighted | $101.44 | $136.05 | $502.31 | -20% |
| Residual income | $25.46 | $26.42 | $27.44 | -85% |
| Analysts' price targets | $155.00 | $209.00 | $246.00 | +22% |
| Tangible book (asset value) | $16.53 | $20.66 | $20.66 | -88% |
| Stage-weighted value (decline / turnaround) | $45.99 | $77.35 | $249.95 | -55% |
| Combined forecast (3 months) | $139.82 | $177.56 | $220.00 | +4% |
| Schwartz–Moon simulation (cash can run out) | $0.00 | $42.02 | $115.83 | -75% |
Ducommun's latest quarter
Ducommun, Q3 2026: revenue $227M (+6% year over year), operating margin 11.4%, net earnings $13.9M, operating cash flow $32.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for DCO stock?
The median of 6 analysts' 12-month targets is $211.00, +24% from $170.76; the range is $155.00 to $246.00. The average rating is strong buy.
What is Ducommun's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $7.71 and $209.00, with a middle value of $42.02 against a price of $170.76. Each method's assumptions are on the page.
Does Ducommun usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is DCO stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.